Search

Author/Creator Benanti, F.

1. Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients. (February 2019)

Authors:
Cabibbo, G.; Celsa, C.; Calvaruso, V.; Petta, S.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Rossi, M.; Magro, B.; Rini, F.; Distefano, M.; Larocca, L.; Prestileo, T.; Malizia, G.; Bertino, G.; Benanti, F.; Licata, A.; Scalisi, I.; Mazzola, G.; Di Rosolini, M.A.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e36
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DIRECT‐ACTING ANTIVIRALS DURING OR AFTER IMMUNO‐CHEMOTHERAPY IN HEPATITIS C VIRUS‐ASSOCIATED DIFFUSE LARGE B‐CELL LYMPHOMAS. (June 2017)

Authors:
Merli, M.; Alric, L.; Mannelli, L.; De Angelis, F.; Ferrari, A.; Capecchi, M.; Pirisi, M.; Visco, C.; Piazza, F.; Loustaud‐Ratti, V.; Goldaniga, M.; Zancanella, M.; Cencini, E.; Marino, D.; Benanti, F.; Rumi, M.; Frigeni, M.; Gotti, M.; Sciarra, R.; Ferretti, V.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
194
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy of oral direct acting antivirals for treatment of advanced chronic hepatitis or compensated cirrhosis due to hepatitis C virus infection: The real-life experience of the Sicily registry. Issue 1 (16th February 2017)

Authors:
Cacciola, I.; Petta, S.; Distefano, M.; Cannavò, M.R.; Davì, A.; Madonia, S.; Calvaruso, V.; Larocca, L.; Di Lorenzo, F.; Digiacomo, A.; Bertino, G.; Licata, A.; Latteri, F.; Benanti, F.; Volpes, R.; Guarneri, L.; Averna, A.; Scalisi, I.; Iacobello, C.; Colletti, P.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e6
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study. Issue 7 (9th August 2017)

Authors:
Cabibbo, G.; Petta, S.; Calvaruso, V.; Cacciola, I.; Cannavò, M. R.; Madonia, S.; Distefano, M.; Larocca, L.; Prestileo, T.; Tinè, F.; Bertino, G.; Giannitrapani, L.; Benanti, F.; Licata, A.; Scalisi, I.; Mazzola, G.; Cartabellotta, F.; Alessi, N.; Barbàra, M.; Russello, M.
Other Names:
Craxì A. investigator.; Di Marco V. investigator.; Cammà C. investigator.; Calvaruso V. investigator.; Petta S. investigator.; Colletti P. investigator.; Mazzola G. investigator.; Licata A. investigator.; Giannitrapani L. investigator.; Corrao S. investigator.; Prestileo T. investigator.; Di Lore...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 46:Issue 7(2017)
Page Start:
688
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. OC.07.1 DIRECT ACTING ANTIVIRALS AFTER SUCCESSFUL TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA IMPROVE SURVIVAL AND REDUCE HEPATIC DECOMPENSATION IN HCV-CIRRHOTIC PATIENTS. (25th March 2019)

Authors:
Celsa, C.; Cabibbo, G.; Calvaruso, V.; Petta, S.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Rossi, M.; Magro, B.; Rini, F.; Distefano, M.; Larocca, L.; Prestileo, T.; Malizia, G.; Bertino, G.; Benanti, F.; Licata, A.; Scalisi, I.; Mazzola, G.; Di Rosolini, M.A.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 2
Page Start:
e94
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs). Issue 1 (16th February 2017)

Authors:
Cabibbo, G.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Calvaruso, V.; Petta, S.; Distefano, M.; Larocca, L.; Prestileo, T.; Tinè, F.; Digiacomo, A.; Bertino, G.; Giannitrapani, L.; Benanti, F.; Davì, A.; Volpes, R.; Scalisi, I.; Iacobello, C.; Mazzola, G.; Cartabellotta, F.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort. (October 2019)

Authors:
Cacciola, I.; Petta, S.; Calvaruso, V.; Cartabellotta, F.; Distefano, M.; Scifo, G.; Di Lorenzo, F.; Sanfilippo, A.; Di Rosolini, M.A.; Davì, A.; Benanti, F.; Cacopardo, B.; Licata, A.; Giannitrapani, L.; Cannavò, M.R.; Russello, M.; Madonia, S.; Bavetta, M.G.; Digiacomo, A.; Averna, A.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 3
Page Start:
e262
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗